CORT News

Pomerantz LLP Advises Investors of Class Action Filing Involving Corcept Therapeutics Incorporated – CORT

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

CORT SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Corcept Therapeutics Incorporated Investors - Contact Kirby McInerney LLP by April 21, 2026

Pomerantz LLP Advises Investors of Class Action Filing Involving Corcept Therapeutics Incorporated – CORT

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action – CORT

Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts CORT Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

DEADLINE ALERT for KD, PYPL, SMR, and CORT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm

Lifshitz Law PLLC Announces Investigations of Corcept Therapeutics, Inc. (Nasdaq:CORT), Zynex, Inc. (OTC:ZYXIQ), NuScale Power Corporation (NYSE:SMR), and PayPal Holdings, Inc. (Nasdaq:PYPL)

Pomerantz LLP Advises Investors of Class Action Filing Against Corcept Therapeutics Incorporated – CORT